Ignite Creation Date:
2024-07-17 @ 10:47 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06474039
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-06-19
Brief Title:
The Efficacy of Fluticasone FuroateVilanterolUmeclidinium Compared With VilanterolUmeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD
Sponsor:
Mahidol University
Organization:
Mahidol University
Study Overview
Official Title:
The Efficacy of Fluticasone FuroateVilanterolUmeclidinium Compared With VilanterolUmeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to demonstrate the effects of triple therapy ICSLABALAMA and dual bronchodilators LAMALABA on air trapping in the lungs COPD patients and inflammatory mediators
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None